Re: Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Exempt Distribution

in response to

Exempt Distribution

RVXoldtimer

posted on Feb 19, 2021 09:10AM

"ZHCLF" OTC is trading at $0.54 US (~CAN $0.70), Don is managing to find buyers at CAN $2.54. Don't know where he finds these investors. You gotta hand it to him!